Life Healthcare Group Limited (0928.HK)
HKD 0.05
(-7.69%)
HKD 0.05
(-7.69%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 27.68 Million HKD | 174.58% |
| 2022 | -26.72 Million HKD | -35.53% |
| 2021 | -29.17 Million HKD | -312.04% |
| 2020 | 9.68 Million HKD | 291.04% |
| 2019 | -17.55 Million HKD | 95.74% |
| 2018 | -113.78 Million HKD | -57.49% |
| 2017 | -77.33 Million HKD | -184.09% |
| 2016 | -32.95 Million HKD | 32.11% |
| 2015 | -33.57 Million HKD | 2.87% |
| 2014 | -41.27 Million HKD | 64.33% |
| 2013 | -65.58 Million HKD | -5.49% |
| 2012 | -93.83 Million HKD | -108.37% |
| 2011 | 1.31 Billion HKD | 17658.82% |
| 2010 | -55.52 Million HKD | -194.47% |
| 2009 | 7.9 Million HKD | 133.21% |
| 2008 | -23.79 Million HKD | 99.07% |
| 2007 | -2.57 Billion HKD | -861.02% |
| 2006 | 337.82 Million HKD | 24.06% |
| 2005 | 308.05 Million HKD | 15.97% |
| 2004 | 234.8 Million HKD | 28.66% |
| 2003 | 182.49 Million HKD | 13.2% |
| 2002 | 161.2 Million HKD | 41.45% |
| 2001 | 113.96 Million HKD | 12.36% |
| 2000 | 101.43 Million HKD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 Q2 | 4.89 Million HKD | 0.0% |
| 2023 Q4 | 16.33 Million HKD | 0.0% |
| 2023 FY | - HKD | 174.58% |
| 2022 Q2 | -1.61 Million HKD | 0.0% |
| 2022 FY | - HKD | -35.53% |
| 2022 Q4 | -26.86 Million HKD | 0.0% |
| 2021 Q2 | -443 Thousand HKD | 0.0% |
| 2021 Q4 | -20.56 Million HKD | 0.0% |
| 2021 FY | - HKD | -312.04% |
| 2020 Q4 | -5.77 Million HKD | 0.0% |
| 2020 FY | - HKD | 291.04% |
| 2020 Q2 | 6.44 Million HKD | 0.0% |
| 2019 Q4 | -179 Thousand HKD | 0.0% |
| 2019 FY | - HKD | 95.74% |
| 2019 Q2 | -3.54 Million HKD | 0.0% |
| 2018 Q2 | -38.78 Million HKD | 0.0% |
| 2018 FY | - HKD | -57.49% |
| 2017 FY | - HKD | -184.09% |
| 2017 Q2 | -33.46 Million HKD | 0.0% |
| 2016 Q2 | -13.85 Million HKD | 0.0% |
| 2016 FY | - HKD | 32.11% |
| 2015 Q2 | -17.58 Million HKD | 0.0% |
| 2015 Q4 | -22.5 Million HKD | 0.0% |
| 2015 FY | - HKD | 2.87% |
| 2014 Q2 | -27.39 Million HKD | -5.95% |
| 2014 Q1 | -25.85 Million HKD | 0.0% |
| 2014 FY | - HKD | 64.33% |
| 2014 Q4 | -13.88 Million HKD | 0.0% |
| 2013 Q1 | -29.59 Million HKD | 0.0% |
| 2013 FY | - HKD | -5.49% |
| 2013 Q4 | -25.85 Million HKD | 0.0% |
| 2013 Q3 | -25.85 Million HKD | 37.86% |
| 2013 Q2 | -41.6 Million HKD | -40.59% |
| 2012 Q1 | 327.73 Million HKD | 0.0% |
| 2012 FY | - HKD | -108.37% |
| 2012 Q4 | -29.59 Million HKD | 0.0% |
| 2012 Q3 | -29.59 Million HKD | -109.03% |
| 2012 Q2 | 327.73 Million HKD | 0.0% |
| 2011 Q4 | 327.73 Million HKD | 0.0% |
| 2011 FY | - HKD | 17658.82% |
| 2011 Q1 | -23.04 Million HKD | 0.0% |
| 2011 Q2 | -23.04 Million HKD | 0.0% |
| 2011 Q3 | 327.73 Million HKD | 1522.14% |
| 2010 Q3 | -23.04 Million HKD | -1315.45% |
| 2010 Q1 | 1.89 Million HKD | 0.0% |
| 2010 Q2 | 1.89 Million HKD | 0.0% |
| 2010 FY | - HKD | -194.47% |
| 2010 Q4 | -23.04 Million HKD | 0.0% |
| 2009 Q1 | -8.45 Million HKD | 0.0% |
| 2009 Q2 | -8.45 Million HKD | 0.0% |
| 2009 Q3 | 1.89 Million HKD | 122.42% |
| 2009 Q4 | 1.89 Million HKD | 0.0% |
| 2009 FY | - HKD | 133.21% |
| 2008 Q1 | -643.53 Million HKD | 0.0% |
| 2008 FY | - HKD | 99.07% |
| 2008 Q3 | -8.45 Million HKD | 98.69% |
| 2008 Q2 | -643.53 Million HKD | 0.0% |
| 2008 Q4 | -8.45 Million HKD | 0.0% |
| 2007 Q2 | 96.51 Million HKD | 0.0% |
| 2007 Q1 | 96.51 Million HKD | 0.0% |
| 2007 FY | - HKD | -861.02% |
| 2007 Q4 | -643.53 Million HKD | 0.0% |
| 2007 Q3 | -643.53 Million HKD | -766.75% |
| 2006 Q3 | 96.51 Million HKD | 41.78% |
| 2006 Q2 | 68.07 Million HKD | 0.0% |
| 2006 Q1 | 68.07 Million HKD | 0.0% |
| 2006 FY | - HKD | 24.06% |
| 2006 Q4 | 96.51 Million HKD | 0.0% |
| 2005 Q4 | 68.07 Million HKD | 0.0% |
| 2005 Q2 | 58.7 Million HKD | 0.0% |
| 2005 Q1 | 58.7 Million HKD | 0.0% |
| 2005 FY | - HKD | 15.97% |
| 2005 Q3 | 68.07 Million HKD | 15.97% |
| 2004 Q4 | 58.7 Million HKD | 0.0% |
| 2004 Q1 | 45.62 Million HKD | 0.0% |
| 2004 FY | - HKD | 28.66% |
| 2004 Q2 | 45.62 Million HKD | 0.0% |
| 2004 Q3 | 58.7 Million HKD | 28.66% |
| 2003 Q4 | 45.62 Million HKD | 0.0% |
| 2003 Q2 | 40.3 Million HKD | 0.0% |
| 2003 Q3 | 45.62 Million HKD | 13.2% |
| 2003 FY | - HKD | 13.2% |
| 2003 Q1 | 40.3 Million HKD | 0.0% |
| 2002 Q2 | 28.49 Million HKD | 0.0% |
| 2002 Q1 | 28.49 Million HKD | 0.0% |
| 2002 FY | - HKD | 41.45% |
| 2002 Q4 | 40.3 Million HKD | 0.0% |
| 2002 Q3 | 40.3 Million HKD | 41.45% |
| 2001 Q3 | 28.49 Million HKD | 12.36% |
| 2001 Q2 | 25.35 Million HKD | 0.0% |
| 2001 Q1 | 25.35 Million HKD | 0.0% |
| 2001 FY | - HKD | 12.36% |
| 2001 Q4 | 28.49 Million HKD | 0.0% |
| 2000 Q4 | 25.35 Million HKD | 0.0% |
| 2000 Q3 | 25.35 Million HKD | 0.0% |
| 2000 FY | - HKD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| China Biotech Services Holdings Limited | -73.45 Million HKD | 137.693% |